Recommendations for the reporting of prostate carcinoma

Virchows Archiv

Volumn 451, Issue 4, 2007, Pages 751-756

  Epstein, Jonathan I ^a   Srigley, John ^b   Grignon, David ^c   Humphrey, Peter ^d   Otis, Christopher ^e  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b CREDIT VALLEY HOSPITAL   (Canada)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e BAYSTATE MEDICAL CENTER   (United States)

Author keywords

ADASP; Prostate; Prostate practice guidelines

Indexed keywords

CANCER DIAGNOSIS; CANCER STAGING; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; PROSTATIC INTRAEPITHELIAL NEOPLASIA; REVIEW; SEMINAL VESICLE;

BIOPSY; HUMANS; MALE; NEOPLASM STAGING; PATHOLOGY; PROGNOSIS; PROSTATIC NEOPLASMS;

EID: 34848869014     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-007-0441-4     Document Type: Review

References (14)

1. Amin M, Boccon-Gibod L, Egevad L et al (2004) Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens. (WHO-sponsored International Consultation Consensus). Scand J Urol Nephrol 39(suppl 216):20-33
2. Eble JN, Sauter G, Epstein JI, Sesterhenn IA (2004) Pathology and genetics of tumours of the urinary system and male genital organs. IARC, Lyon; PB 162-192
3. Epstein JI (1991) The evaluation of radical prostatectomy specimens: therapeutic and prognostic implications. Pathol Annu 26:159-210
4. Epstein JI, Amin M, Boccon-Gibod L et al (2004) Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. (WHO-sponsored International Consultation Consensus). Scand J Urol Nephrol 39(suppl 216):34-63
5. Grignon DJ, Sakr WA (1996) Pathologic staging of prostate carcinoma: what are the issues. Cancer 78:337-340
6. May F, Hartung R, Breul J (2001) The ability of the American Joint Committee on Cancer Staging system to predict progression-free survival after radical prostatectomy. BJU Int 88:702-707
7. Ohori M, Kattan M, Scardino PT, Wheeler TM (2004) Radical prostatectomy for carcinoma of the prostate. Mod Path 17:349-359
8. Young RH, Srigley JR, Amin MB, Ulbright TM, Cubilla A (2000) Tumors of the prostate gland, seminal vesicle, male urethra and penis. In: Atlas of tumor pathology. Series 3. Armed Forces Institute of Pathology, Washington, DC
9. Epstein JI, Allsbrook WC, Amin MB, Egevad LL. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 29:1228-1242
10. Gleason DR, Mellinger GT (1974) The Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostate adenocarcinoma by combined histological grading and clinical staging. J Urol 111:58-64
11. Epstein JI, Herawi M (2006) Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol 175:820-834
12. Eichelberger LE, Cheng L (2004) Does pT2b prostate cancer exist? Critical appraisal of the 2002 TNM classification of prostate cancer. Cancer 100:2573-2576
13. Freedland SJ, Partin AW, Epstein JI, Walsh PC (2004) Biochemical failure after radical prostatectomy in men with pathologic organ-confined prostate cancer: pT2 versus pT2b. Cancer 100:1646-1649
14. Humphrey PA, Walther PJ (1993) Adenocarcinoma of the prostate, I: simple sampling considerations. Am J Clin Pathol 99:746-759